BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○

Ibogaine

One of several indole alkaloids extracted from Tabernanthe iboga, Baill. It has a complex pharmacological profile, and interacts with multiple systems of neurotransmission. Ibogaine has psychoactive properties and appears to modulate tolerance to opiates.

300+ PubMed studies analyzed · 3 RCTs · Evidence Score: 41.9

Research Domains

Ibogaine has been studied across 16 research domains including 🌤️ Mood & Depression, 💊 Pain, 🧠 Focus & Attention, 🫁 Liver & Detox, 🧠 Learning. The primary research focus is 🌤️ Mood & Depression with 23% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Ibogaine, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

Lobeline
6 shared targets
Ritodrine
5 shared targets
loperamide
5 shared targets
carbetapentane
4 shared targets
ifenprodil
4 shared targets
Arecoline
6 shared targets
Tolterodine
4 shared targets
Dihydro-beta-Erythroidine
3 shared targets
Levorphanol
5 shared targets
Mecamylamine
4 shared targets
Loading evidence profile...

This evidence profile for Ibogaine is generated deterministically from 300 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.